Research File 004
Gene Editing &
CRISPR
Life is code. DNA is the source file. CRISPR is the text editor. In 2012 humans gained the ability to rewrite the code of life — and the implications are staggering.
Life is code. DNA is the source file. CRISPR is the text editor. In 2012 humans gained the ability to rewrite the code of life — and the implications are staggering.
DNA is a double-helix molecule built from four nucleotide bases: Adenine (A), Thymine (T), Guanine (G), Cytosine (C). They pair specifically (A–T, G–C) forming the "rungs" of the ladder. The sequence of these bases IS the genetic code — instructions for every protein your body makes.
Every one of the ~37 trillion cells in your body contains the complete 3.2 billion-character genome. What makes a liver cell different from a neuron is not the DNA — but which genes are switched on or off. That's epigenetics.
CRISPR was originally a bacterial immune system — bacteria use it to remember and cut viral DNA. Scientists realized it could be reprogrammed to cut any target DNA sequence. Before CRISPR, gene editing existed but cost thousands of dollars and took months. CRISPR reduced cost to hundreds and time to days.
The first CRISPR-based cure was FDA-approved in December 2023. Patients' bone marrow stem cells are edited to reactivate fetal haemoglobin — bypassing the broken adult version. Functionally cures a disease that crippled millions of lives.
CAR-T cells — patient's own immune cells edited to specifically recognise and destroy cancer cells. Remarkable results in blood cancers. Some patients with terminal lymphoma reaching complete remission.
Wheat edited to resist powdery mildew. Tomatoes that stay firm longer. Rice varieties needing less water. No foreign DNA introduced — just precise edits to existing genes. Many countries treat this differently from GMOs.
COVID-19 vaccines use lipid nanoparticles — nanoscale engineering — to deliver mRNA instructions into cells. This is applied molecular biology that vaccinated billions. A direct result of decades of foundational gene research.
Somatic editing — editing cells in a living person — is broadly accepted. Effects stay with that person only. Sickle cell cure is somatic editing. Cancer therapy is somatic.
Germline editing — editing embryos, eggs, or sperm — is different in kind. Every change is inherited by all future descendants permanently. The scientific community has a near-universal consensus: this requires extreme caution and strong oversight before any clinical use.
In 2018, Chinese scientist He Jiankui secretly created the first germline-edited human babies. He was sentenced to prison — not just for the ethics, but because the science wasn't careful enough to be safe.
Somatic editing to cure genetic diseases in living patients. Informed consent, patient benefits directly, effects are non-heritable. The scientific and ethical justification is strong.
Editing embryos to prevent inherited diseases. Benefits could be large. But heritable effects, off-target risks, and irreversibility make this deeply controversial. No clear consensus yet.
Editing for traits like intelligence, height, athleticism. Raises profound questions about inequality, identity, and what it means to be human. Where does treatment end and enhancement begin?